Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001780081-26-000004

Director sold 33,243 shares at $39.74 ($1,320,964)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Krainer Adrian R. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-10 Sale : show line 1 in the form 10b5-1 −33,243 $39.74 $1,320,964 283,302 D
Open-market sales · 33,243 sh · avg $39.74 · $1,320,964
Loading xslF345X05/form4-03122026_080302.xml…